B. Farthmann

Malignant melanoma--markers for progression and prognosis in malignant melanoma.

A. Milling, C. Geilen, J. Georgieva, 2006, Frontiers of radiation therapy and oncology.

Cerebriform nodular amelanotic metastases of malignant melanoma: a challenge in differential diagnosis of a rare variant

U. Blume-Peytavi, E. Dippel, C. Orfanos, 2000, The British journal of dermatology.

Elevated plasma levels of transforming growth factor (TGF)-beta1 and TGF-beta2 in patients with disseminated malignant melanoma.

U. Mansmann, J. Eberle, C. Orfanos, 1998, British Journal of Cancer.

RT-PCR for tyrosinase-mRNA-positive cells in peripheral blood: evaluation strategy and correlation with known prognostic markers in 123 melanoma patients.

J. Eberle, M. Gstöttner, C. Orfanos, 1998, The Journal of investigative dermatology.

Referral of Patients to Dermatology and Teledermatology Consultations in Spain. DIADERM Study

R. Grimalt, J. A. Sánchez, S. Arias-Santiago, 2019, Actas Dermo-Sifiliográficas (English Edition).

Photoprotection by Total Melanin Content and Pigment Phenotype (Eumelanin, Pheomelanin) in Human Melanoma Cell Lines

C. Orfanos, K. Krasagakis, S. Schmitz, 1996 .